»ï¼º¼¿ïº´¿ø "The First Precision Oncology Forum at SMC : Today's Cancer Research for Tomorrow's Cancor Cure" : 2023-03-31
±³À°ÀÏÀÚ : 2023-03-31
±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B1 ¾Ïº´¿ø °´ç
±³À°ÁÖÁ¦ : "The First Precision Oncology Forum at SMC : Today's Cancer Research for Tomorrow's Cancor Cure"
ÁÖÃÖ±â°ü : »ï¼º¼¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : Ç÷¾×Á¾¾ç³»°ú
´ã´çÀÚ : ³ëÀÎÈñ
¿¬¶ôó : 02-2148-9826
À̸ÞÀÏ : ilpm.smc@samsung.com
±³À°Á¾·ù : ÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 13:00~13:10 Welcome Messages from SMC leadership ¹Ú½Â¿ì À̱Լº ÀÌ¿ì¿ë(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 13:10~13:15 SMC Precision Medicine Program: our 10-year journey ¹ÚÁØ¿À(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 13:15~13:30 Overview of Cancer Precision Medicine: a new era yet to come È«Á¤¿ë(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 13:30~13:55 Bringing Science into the patients: the cell-free DNA journey AmirAli Talasaz(Guardant Health Inc)
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 13:55~14:15 Neoantigen targeted therapeutic vaccination ¹é¼ø¸í(Theragenbio)
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 14:15~14:35 Precision Oncology Center at SMC : a 10-year journey and what is next? ÀÌÁö¿¬(»ï¼º¼¿ïº´¿ø)
ÈÞ½Ä 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 14:35~14:45 ()
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 14:45~15:05 AI driven multiplex proteomics to predict response to immunotherapy ÇãÀ¯Á¤(Neocella)
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 15:05~15:25 Patient-derived organoids as a potential model to predict response to immunotheraphy ±¸º¸¼º(MBD(Medical& Bio Decision))
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 15:25~15:45 AZ drug development for oncology unmet needs Viia Valge-Archer(Astra Zeneca)
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 15:45~16:05 Advancing the MSD oncology pipeline to address patient unmet medical needs Andrea LAUER(Merck MSD)
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 16:05~16:20 Plasma proteomics for early detection and treatment response Rocky Choi(Olink)
±³À°½Ã°£ 03-31 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ 1Ãþ ´ë°´ç 16:20~16:35 Facilitating Precision Oncology with Metabolomics : Expanding Applications in Cancer Care Natasa Giallourou(Metabolon)